Kamat Nikhil V, Thabet Salim R, Xiao Liang, Saleh Mohamed A, Kirabo Annet, Madhur Meena S, Delpire Eric, Harrison David G, McDonough Alicia A
From the Department of Cell and Neurobiology, Keck School of Medicine of USC, Los Angeles, CA (N.V.K., A.A.M.); Division of Clinical Pharmacology, Department of Medicine (S.R.T., L.X., M.A.S., A.K., M.S.M., D.G.H.) and Department of Anesthesiology (E.D.), Vanderbilt University School of Medicine, Nashville, TN; and Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt (M.A.S.).
Hypertension. 2015 Mar;65(3):569-76. doi: 10.1161/HYPERTENSIONAHA.114.04975. Epub 2015 Jan 19.
Ample genetic and physiological evidence establishes that renal salt handling is a critical regulator of blood pressure. Studies also establish a role for the immune system, T-cell infiltration, and immune cytokines in hypertension. This study aimed to connect immune cytokines, specifically interferon-γ (IFN-γ) and interleukin-17A (IL-17A), to sodium transporter regulation in the kidney during angiotensin-II (Ang-II) hypertension. C57BL/6J (wild-type) mice responded to Ang-II infusion (490 ng/kg per minute, 2 weeks) with a rise in blood pressure (170 mm Hg) and a significant decrease in the rate of excretion of a saline challenge. In comparison, mice that lacked the ability to produce either IFN-γ (IFN-γ(-/-)) or IL-17A (IL-17A(-/-)) exhibited a blunted rise in blood pressure (<150 mm Hg), and both the genotypes maintained baseline diuretic and natriuretic responses to a saline challenge. Along the distal nephron, Ang-II infusion increased abundance of the phosphorylated forms of the Na-K-2Cl cotransporter, Na-Cl cotransporter, and Ste20/SPS-1-related proline-alanine-rich kinase, in both the wild-type and the IL-17A(-/-) but not in IFN-γ(-/-) mice; epithelial Na channel abundance increased similarly in all the 3 genotypes. In the proximal nephron, Ang-II infusion significantly decreased abundance of Na/H-exchanger isoform 3 and the motor myosin VI in IL-17A(-/-) and IFN-γ(-/-), but not in wild-type; the Na-phosphate cotransporter decreased in all the 3 genotypes. Our results suggest that during Ang-II hypertension both IFN-γ and IL-17A production interfere with the pressure natriuretic decrease in proximal tubule sodium transport and that IFN-γ production is necessary to activate distal sodium reabsorption.
大量的遗传学和生理学证据表明,肾脏对盐的处理是血压的关键调节因素。研究还证实了免疫系统、T细胞浸润和免疫细胞因子在高血压中的作用。本研究旨在将免疫细胞因子,特别是干扰素-γ(IFN-γ)和白细胞介素-17A(IL-17A)与血管紧张素-II(Ang-II)高血压期间肾脏中钠转运体的调节联系起来。C57BL/6J(野生型)小鼠对Ang-II输注(每分钟490 ng/kg,持续2周)的反应是血压升高(170 mmHg),盐水激发试验的排泄率显著降低。相比之下,缺乏产生IFN-γ(IFN-γ(-/-))或IL-17A(IL-17A(-/-))能力的小鼠血压升高不明显(<150 mmHg),两种基因型对盐水激发试验均维持基线利尿和利钠反应。在远端肾单位,Ang-II输注增加了野生型和IL-17A(-/-)小鼠中Na-K-2Cl共转运体、Na-Cl共转运体和Ste20/SPS-1相关富含脯氨酸-丙氨酸激酶的磷酸化形式的丰度,但在IFN-γ(-/-)小鼠中未增加;上皮钠通道丰度在所有三种基因型中均有类似增加。在近端肾单位,Ang-II输注显著降低了IL-17A(-/-)和IFN-γ(-/-)小鼠中Na/H交换体亚型3和运动肌球蛋白VI的丰度,但在野生型小鼠中未降低;Na-磷酸盐共转运体在所有三种基因型中均减少。我们的结果表明,在Ang-II高血压期间,IFN-γ和IL-17A的产生均干扰近端小管钠转运中压力利钠的降低,并且IFN-γ的产生是激活远端钠重吸收所必需的。